Shree Pacetronix (BOM:527005) Cyclically Adjusted Revenue per Share: ₹44.36 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:527005 Shree Pacetronix Ltd BOM:527005
83 GF Score
Price ₹137.25
GF Value ₹163.45
Valuation Modestly Undervalued
View Full Analysis

What is Shree Pacetronix Cyclically Adjusted Revenue per Share?

Shree Pacetronix BOM:527005 -7.01% 83 Cyclically Adjusted Revenue per Share is ₹44.36 as of Mar. 2026. GuruFocus rates BOM:527005 with a GF Score™ of 83/100 and a GF Value™ of ₹163.45 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shree Pacetronix's adjusted revenue per share for the three months ended in Mar. 2026 was ₹14.440. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹44.36 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-11), Shree Pacetronix's current stock price is ₹137.25. Shree Pacetronix's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹44.36. Shree Pacetronix's Cyclically Adjusted PS Ratio of today is 3.09.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shree Pacetronix was 6.33. The lowest was 1.82. And the median was 3.24.


Shree Pacetronix  (BOM:527005) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shree Pacetronix's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=137.25/44.36
=3.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shree Pacetronix was 6.33. The lowest was 1.82. And the median was 3.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shree Pacetronix Cyclically Adjusted Revenue per Share Related Terms


Shree Pacetronix Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Shree Pacetronix's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shree Pacetronix Cyclically Adjusted Revenue per Share Chart

Shree Pacetronix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 44.36

Shree Pacetronix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 41.66 43.28 43.69 44.36

BOM:527005 vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Shree Pacetronix's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shree Pacetronix Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shree Pacetronix's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shree Pacetronix's Cyclically Adjusted PS Ratio falls into.


BOM:527005
83GF Score
Shree Pacetronix Ltd BOM:527005
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shree Pacetronix Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shree Pacetronix's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=14.44/164.2724*164.2724
=14.440

Current CPI (Mar. 2026) = 164.2724.

Shree Pacetronix Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201409 7.956 96.780 13.504
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 4.165 109.786 6.232
201806 4.818 111.317 7.110
201809 4.960 115.142 7.076
201812 5.207 115.142 7.429
201903 5.280 118.202 7.338
201906 5.042 120.880 6.852
201909 6.825 123.175 9.102
201912 5.249 126.235 6.831
202003 7.261 124.705 9.565
202006 4.685 127.000 6.060
202009 5.229 130.118 6.602
202012 5.629 130.889 7.065
202103 6.015 131.771 7.499
202106 4.708 134.084 5.768
202109 7.956 135.847 9.621
202112 6.088 138.161 7.239
202203 6.504 138.822 7.696
202206 9.277 142.347 10.706
202209 11.655 144.661 13.235
202212 14.483 145.763 16.322
202303 20.883 146.865 23.358
202306 16.262 150.280 17.776
202309 14.553 151.492 15.781
202312 11.917 152.924 12.801
202403 18.503 153.035 19.862
202406 13.421 155.789 14.152
202409 10.801 157.882 11.238
202412 10.115 158.323 10.495
202503 11.856 157.552 12.362
202506 14.871 159.755 15.291
202509 18.316 162.289 18.540
202512 12.061 163.281 12.134
202603 14.440 164.272 14.440

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹44.36 mean?
Shree Pacetronix (BOM:527005) has a Cyclically Adjusted Revenue per Share of ₹44.36 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shree Pacetronix and its competitors.
Is Shree Pacetronix's Cyclically Adjusted Revenue per Share too high?
Shree Pacetronix's current Cyclically Adjusted Revenue per Share is ₹44.36. Overall, Shree Pacetronix has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shree Pacetronix's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Shree Pacetronix's Cyclically Adjusted Revenue per Share of ₹44.36 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shree Pacetronix and its competitors. Shree Pacetronix's current Cyclically Adjusted Revenue per Share is ₹44.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Pacetronix stock overvalued right now?
Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹163.45, compared to a current price of ₹137.25 — trading 16% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹44.36. Shree Pacetronix's overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current Cyclically Adjusted Revenue per Share is ₹44.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shree Pacetronix (BOM:527005) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Pacetronix stock appears to be undervalued. The current stock price of ₹137.25 is trading 16% below its estimated GF Value™ of ₹163.45. GuruFocus considers Shree Pacetronix to be Modestly Undervalued.

Key valuation signals for BOM:527005:

  • Cyclically Adjusted Revenue per Share: ₹44.36
  • GF Value™: ₹163.45 vs. price of ₹137.25 (16% below fair value)
  • GF Score™: 83/100

No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shree Pacetronix Business Description

Address Plot Number 15, Sector II, Industrial Area, District Dhar, Pithampur, MP, IND, 454775
Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.
83GF Score

Get the complete analysis for BOM:527005

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹137.25
Price
₹163.45
GF Value